Continuous Glucose Monitoring in Individuals With Type 2 Diabetes: A Quality Improvement Program

Overview

Journal Clin Diabetes

Date 2025 Jan 20

PMID 39829704

Authors

Lynne Kinson

Kim Inman

Affiliations

Soon will be listed here.

References

Polonsky W, Layne J, Parkin C, Kusiak C, Barleen N, Miller D . Impact of Participation in a Virtual Diabetes Clinic on Diabetes-Related Distress in Individuals With Type 2 Diabetes. Clin Diabetes. 2020; 38(4):357-362. PMC: 7566922. DOI: 10.2337/cd19-0105. View

Fang M, Wang D, Coresh J, Selvin E . Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018. N Engl J Med. 2021; 384(23):2219-2228. PMC: 8385648. DOI: 10.1056/NEJMsa2032271. View

Davidson J . The increasing role of primary care physicians in caring for patients with type 2 diabetes mellitus. Mayo Clin Proc. 2010; 85(12 Suppl):S3-4. PMC: 2996164. DOI: 10.4065/mcp.2010.0466. View

Grunberger G, Sherr J, Allende M, Blevins T, Bode B, Handelsman Y . American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr Pract. 2021; 27(6):505-537. DOI: 10.1016/j.eprac.2021.04.008. View

Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J, Rayman G . Use of Flash Glucose-Sensing Technology for 12 months as a Replacement for Blood Glucose Monitoring in Insulin-treated Type 2 Diabetes. Diabetes Ther. 2017; 8(3):573-586. PMC: 5446381. DOI: 10.1007/s13300-017-0255-6. View

Heinemann L, Freckmann G, Ehrmann D, Faber-Heinemann G, Guerra S, Waldenmaier D . Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Lancet. 2018; 391(10128):1367-1377. DOI: 10.1016/S0140-6736(18)30297-6. View

Ruedy K, Parkin C, Riddlesworth T, Graham C . Continuous Glucose Monitoring in Older Adults With Type 1 and Type 2 Diabetes Using Multiple Daily Injections of Insulin: Results From the DIAMOND Trial. J Diabetes Sci Technol. 2017; 11(6):1138-1146. PMC: 5951040. DOI: 10.1177/1932296817704445. View

Aronson R, Brown R, Chu L, Bajaj H, Khandwala H, Abitbol A . IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trial. Diabetes Obes Metab. 2022; 25(4):1024-1031. DOI: 10.1111/dom.14949. View

Lind M, Polonsky W, Hirsch I, Heise T, Bolinder J, Dahlqvist S . Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial. JAMA. 2017; 317(4):379-387. DOI: 10.1001/jama.2016.19976. View

10.

Holman R, Paul S, Bethel M, Matthews D, Neil H . 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359(15):1577-89. DOI: 10.1056/NEJMoa0806470. View

11.

Wada E, Onoue T, Kobayashi T, Handa T, Hayase A, Ito M . Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care. 2020; 8(1). PMC: 7292039. DOI: 10.1136/bmjdrc-2019-001115. View

12.

Battelino T, Danne T, Bergenstal R, Amiel S, Beck R, Biester T . Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019; 42(8):1593-1603. PMC: 6973648. DOI: 10.2337/dci19-0028. View

13.

Grunberger G, Sze D, Ermakova A, Sieradzan R, Oliveria T, Miller E . Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States. Clin Diabetes. 2020; 38(1):47-55. PMC: 6969667. DOI: 10.2337/cd19-0008. View

14.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

15.

Vigersky R, Fonda S, Chellappa M, Walker M, Ehrhardt N . Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2011; 35(1):32-8. PMC: 3241321. DOI: 10.2337/dc11-1438. View

16.

Charleer S, De Block C, Van Huffel L, Broos B, Fieuws S, Nobels F . Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes Care. 2019; 43(2):389-397. DOI: 10.2337/dc19-1610. View

17.

Nathan D, Cleary P, Backlund J, Genuth S, Lachin J, Orchard T . Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005; 353(25):2643-53. PMC: 2637991. DOI: 10.1056/NEJMoa052187. View

18.

Van Beers C, DeVries J, Kleijer S, Smits M, Geelhoed-Duijvestijn P, Kramer M . Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016; 4(11):893-902. DOI: 10.1016/S2213-8587(16)30193-0. View

19.

Hayashi I, Watanabe N, Nakata S, Komatsu R, Motoda S, Fujita Y . Factors associated with treatment satisfaction in patients with type 2 diabetes mellitus using oral glucose-lowering agents: a cross-sectional study in urban districts in Japan. Endocr J. 2018; 65(10):1001-1009. DOI: 10.1507/endocrj.EJ18-0182. View

20.

Charleer S, Mathieu C, Nobels F, De Block C, Radermecker R, Hermans M . Effect of Continuous Glucose Monitoring on Glycemic Control, Acute Admissions, and Quality of Life: A Real-World Study. J Clin Endocrinol Metab. 2018; 103(3):1224-1232. DOI: 10.1210/jc.2017-02498. View